References
- World Health Organization. Influenza (seasonal). World Health Organization; Geneva, Switzerland 2014.
- Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; http://dx.doi.org/10.1016/S1473-3099(11)70295-X
- Weinstock DM, Eagan J, Malak SA, Rogers M, Wallace H, Kiehn TE, Sepkowitz KA. Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol 2000; 21:730-2; PMID:11089659; http://dx.doi.org/10.1086/501726
- Mereckiene J, Cotter S, Nicoll A, Levy-Bruhl D, Ferro A, Tridente G, Zanoni G, Berra P, Salmaso S, O'Flanagan D, et al. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill 2008; 13:19017; PMID:18947524
- US Department of Health and Human Services. Healthy People 2020 Objectives for Healthcare Personnel: IID-12.9. Washington, DC: US Government; 2010.
- Pasteur S. Intanza® influenza vaccine (split virion, inactivated). Toronto, Canada; 2012:31.
- Coleman BL, McGeer AJ, Halperin SA, Langley JM, Shamout Y, Taddio A, Shah V, McNeil SA. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine 2012; 30:6287-93; PMID:22902784; http://dx.doi.org/10.1016/j.vaccine.2012.08.006
- Hoon Han S, Hee Woo J, Weber F, Joo Kim W, Ran Peck K, Il Kim S, Hwa Choi Y, Myung Kim J. Immunogenicity and safety of Intanza®/IDflu® intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial. Human Vaccines and Immunotherapeutics 2013; 9:1971-7; PMID:23778938; http://dx.doi.org/10.4161/hv.25295
- Beran J, Ambrozaitis A, Laiskonis A, Mickuviene N, Bacart P, Calozet Y, Demanet E, Heijmans S, Van Belle P, Weber F, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Medicine 2009; 7:13; PMID:19341446; http://dx.doi.org/10.1186/1741-7015-7-13
- Ribner BS, Hall C, Steinberg JP, Bornstein WA, Chakkalakal R, Emamifar A, Eichel I, Lee PC, Castellano PZ, Grossman GD. Use of a mandatory declination form in a program for influenza vaccination of healthcare workers. Infection Control Hospital Epidemiology 2008; 29:302-8; PMID:18462141; http://dx.doi.org/10.1086/529586
- Bertin M, Scarpelli M, Proctor AW, Sharp J, Robitson E, Donnelly T, Young C, Gordon SM. Novel use of the intranet to document health care personnel participation in a mandatory influenza vaccination reporting program. Am J Infect Control 2007; 35:33-7; PMID:17276789; http://dx.doi.org/10.1016/j.ajic.2006.10.005
- Kimura AC, Higa JI, Nguyen C, Vugia DJ, Dysart M, Ellingson L, Chelstrom L, Thurn J, Nichol KL, Poland GA, et al. Interventions to increase influenza vaccination of health-care workers–California and Minnesota. MMWR Morb Mortal Wkly Rep 2005; 54:196-9; PMID:15744227
- Slaunwhite JM, Smith SM, Fleming MT, Strang R, Lockhart C. Increasing vaccination rates among health care workers using unit “champions” as a motivator. Can J Infect Control 2009; 24:159-64; PMID:19891169
- Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 2008; 26:3197-208; PMID:18486285; http://dx.doi.org/10.1016/j.vaccine.2008.03.095
- Nowalk MP, Lin CJ, Toback SL, Rousculp MD, Eby C, Raymund M, Zimmerman RK. Improving influenza vaccination rates in the workplace: a randomized trial. Am J Prev Med 2010; 38:237-46; PMID:20036102; http://dx.doi.org/10.1016/j.amepre.2009.11.011
- Dhont PA, Albert A, Brenders P, Podwapinska A, Pollet A, Scheveneels D, Tihon F, Verheyden I, Victor J, Samson SI. Acceptability of Intanza® 15 mcg intradermal influenza vaccine in Belgium during the 2010-2011 influenza season. Adv Ther 2012; 29:562-77; PMID:22678831; http://dx.doi.org/10.1007/s12325-012-0025-9
- Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Advances in Therapy 2011; 28:640-9; PMID:21751080; http://dx.doi.org/10.1007/s12325-011-0042-0
- Prymula R, Usluer G, Altinel S, Sichova R, Weber F. Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey. Adv Ther 2012; 29:41-52; PMID:22228256; http://dx.doi.org/10.1007/s12325-011-0090-5